- Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19
- Eiger Bio to Participate in September 2020 Investor Conferences
- Eiger Announces Peginterferon Lambda - Lonafarnib Combination End of Treatment Results from Phase 2 LIFT HDV Study in Late Breaker Session at The Digital International Liver Congress™ 2020
- Eiger BioPharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
- Eiger BioPharmaceuticals to Participate in Upcoming August 2020 Investor Conferences
As of last trade,
Eiger BioPharmaceuticals Inc (72C1:DEU) traded at 6.90, 59.72% above the 52 week low of 4.32 set on Mar 16, 2020.
4.32Mar 16 202014.00Dec 27 2019
Markit short selling activity
|Market cap||238.04m USD|
|EPS (TTM)||-2.68 |
Data delayed at least 15 minutes, as of Oct 01 2020 08:59 BST.